Showing results (381-390 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|April 1, 1992
Haloperidol decanoate pharmacokinetics in red blood cells and plasmaM W Dysken, S W Kim, G Vatassery, et al.Journal of Clinical Psychopharmacology|February 1, 1992
Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone)G D Tollefson, J Montague-Clouse, S L TollefsonJournal of Clinical Psychopharmacology|January 22, 2008
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studiesMichael E Thase, Alan Jonas, Arif Khan, et al.Journal of Clinical Psychopharmacology|January 22, 2008
Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidolSahoo Saddichha, Shahul Ameen, Sayeed AkhtarJournal of Clinical Psychopharmacology|January 22, 2008
Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteersAjna Hamidovic, Un Jung Kang, Harriet de WitJournal of Clinical Psychopharmacology|January 22, 2008
Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophreniaLeonardo Cortese, Michael P Caligiuri, Richard Williams, et al.Journal of Clinical Psychopharmacology|January 22, 2008
Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadolJulia Kirchheiner, Jan-Tobias H A Keulen, Steffen Bauer, et al.Journal of Clinical Psychopharmacology|December 1, 1991
Meta-analysis of desipramine as an adjunct in the treatment of cocaine addictionF R Levin, A F LehmanJournal of Clinical Psychopharmacology|May 6, 2008
Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trialsPeter J Weiden, Andrew J Cutler, Mihael H Polymeropoulos, et al.Journal of Clinical Psychopharmacology|May 6, 2008
Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophreniaAndrew J Cutler, Amir H Kalali, Peter J Weiden, et al.Pageof 332